Guardant Health: Q2 Earnings Snapshot

In this article:

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $72.8 million in its second quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of 67 cents.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.25 per share.

The provider of oncology testing services posted revenue of $137.2 million in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $128.8 million.

Guardant Health expects full-year revenue in the range of $545 million to $550 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Advertisement